Literature DB >> 22649341

Fulminant adenocarcinoma of the rectum with hepatic metastasis in a young pregnant woman: a case report.

Edward Araujo Júnior1, Felipe Favorette Campanharo, Sue Yasaki Sun, Luciano Marcondes Machado Nardozza, Rosiane Mattar, Antonio Fernandes Moron.   

Abstract

Cancer is the second leading cause of death during the reproductive years, but the incidence during pregnancy is low. The incidence of cancer of the rectum during pregnancy is very rare (1:50,000 to 1:100,000 pregnancies). Usually, the symptoms of this type of cancer are nonspecific and sometimes they are confused with normal changes of pregnancy. The diagnosis of rectal cancer is usually made in the late stage of pregnancy. The treatment of this cancer involves surgery, chemotherapy and radiotherapy, but each type of treatment involves risks to the fetus and the pregnant woman. We present a case of a young primiparous woman who had a quick and bad evolution of an adenocarcinoma of the rectum diagnosed during pregnancy. This patient had extensive involvement of the liver with metastasis and she died two weeks after diagnosis. In this case, we present the clinical, radiological and pathology findings of this disease.

Entities:  

Keywords:  Cancer of the rectum; Magnetic resonance imaging; Metastasis; Microscopy; Pregnancy

Year:  2012        PMID: 22649341      PMCID: PMC3362226          DOI: 10.1159/000338809

Source DB:  PubMed          Journal:  Case Rep Oncol        ISSN: 1662-6575


Introduction

The incidence of pregnancy-associated cancer is relatively low, complicating 0.02–0.1% of all pregnancies [1]. The most common tumors diagnosed during pregnancy are breast cancer, cervical cancer, melanoma, and leukemias/lymphomas. Lung, gastrointestinal, urological and other malignancies are rarely observed [2]. Cancer of the rectum is a very rare disease during pregnancy, with an incidence of 1:50,000 to 1:100,000 pregnancies. However, mainly in industrialized countries where the incidence of pregnancies in advanced ages is increasing, obstetricians should be vigilant of this disease [3]. We present a case of a young primiparous woman who had a quick and bad evolution of an adenocarcinoma of the rectum diagnosed during pregnancy. In this case, we present the clinical, radiological and pathology findings of this disease.

Case Report

A 17-year-old primiparous woman was admitted to our service with fever (38°C), abdominal pain, weakness and recent weight loss of 5 kg. At general physical exam, she was discolored (+/+4), eupneic and anicteric. Her weight was 66 kg, and she reported a weight of 58 kg before pregnancy. The abdomen was distended and with evident vascularization (fig. ). The liver was enlarged, hardened and several nodules were observed. Soft edema (Godet sign) was present in the lower members (fig. 1b). The obstetric exam showed a fundal height of 14.0 cm and a fetal heart rate of 144 beats per minute. The laboratory exams showed Hb/Ht of 12.7 g/dl/38%, fasting glucose of 89 mg/dl, α-fetoprotein of 75.25 ng/dl and carcinoembryonic antigen of 4,487 ng/ml. She was hospitalized, and T2-sequence magnetic resonance imaging in the coronal plane was performed, which revealed an enlarged liver, with several nodules with central hypersignal, suggestive of metastasis (fig. ). The obstetrical scan evidenced a unique and topic pregnancy with the fetus presenting biometric parameters of 21 weeks. The fetus showed no malformations, the amniotic fluid volume was normal and the estimated fetal weight was 411 g. The patient progressed to vomiting blood, and there was also blood in her stool. The liver biopsy confirmed infiltration by adenocarcinoma with several metastases (fig. ). The sigmoidoscopy evidenced an ulcerative-vegetative lesion 10.0 cm from the anal verge; the biopsy confirmed adenocarcinoma of the rectum (fig. 3b). The patient evolved with significant abdominal pain, hypotension and cardiopulmonary arrest. Death occurred two weeks after hospitalization. Necropsy confirmed the diagnosis of adenocarcinoma of the rectum with liver metastases.
Fig. 1

a Abdominal distension with evident vascularization. b Soft edema (Godet sign) of lower members.

Fig. 3

a Photomicrograph of liver biopsy showing the positive immunohistochemical reaction to carcinoembryonic antigen. b Photomicrograph of rectal biopsy with hematoxylin and eosin confirming the diagnosis of adenocarcinoma.

Discussion

During pregnancy a woman's body undergoes physiological changes that may make the diagnosis of several cancers more challenging [4]. Cancer of the rectum presents with different patterns of development; in some cases it is insidious and in others it quickly progresses. In our case the adenocarcinoma of the rectum led to a fulminant outcome, with the patient dying two weeks after diagnosis. It is not clear if the pregnancy can modify the course of this disease. The diagnosis of adenocarcinoma of the rectum during pregnancy usually occurs in an advanced stage, and the clinical signs are rectal bleeding, transit disorder with alternating diarrhea and constipation, meteorism, abdominal pain or anemia [5]. These symptoms usually are confused with the physiological modifications during pregnancy or hemorrhoid disease. In our case the patient had rectal bleeding and abdominal pain. The vomiting of blood probably occurred due to hepatic involvement. The treatment of cancer of the rectum during pregnancy depends on staging and some other parameters such as location, size and period of the pregnancy (first or second half). Surgery during pregnancy involves the risk of bleeding and miscarriage if done before 14 weeks [6]. Chemotherapy can be started during the second or third trimester without increased risk of fetal loss or malformation [7]. Radiotherapy is not possible during pregnancy because of the risk of lethal fetal malformation, and it should be delayed until after labor. Another risk of radiotherapy in young women is castration [8]. In summary, we presented a case of a fulminant outcome of adenocarcinoma of the rectum in a young pregnant woman. New studies are necessary to assess if the pregnancy induces changes in the course of this type of cancer.
  8 in total

Review 1.  Cancer and pregnancy: poena magna, not anymore.

Authors:  George Pentheroudakis; Nicholas Pavlidis
Journal:  Eur J Cancer       Date:  2005-12-02       Impact factor: 9.162

Review 2.  Cancer in pregnancy: maternal and fetal implications.

Authors:  B Weisz; E Schiff; M Lishner
Journal:  Hum Reprod Update       Date:  2001 Jul-Aug       Impact factor: 15.610

Review 3.  Cancer of the colon, rectum, and anus during pregnancy. The surgeon's perspective.

Authors:  C Walsh; V W Fazio
Journal:  Gastroenterol Clin North Am       Date:  1998-03       Impact factor: 3.806

Review 4.  [Management of rectal cancer in pregnant women].

Authors:  Hugo Pigeau; Pierre-François Dupré; Jaafar Benouna; Jean-Marie Classe; Raphaëlle Pioud; Marc Audré Mahé; François Dravet
Journal:  Bull Cancer       Date:  2005-11       Impact factor: 1.276

Review 5.  Cancer in pregnancy: gaps, challenges and solutions.

Authors:  David Pereg; Gideon Koren; Michael Lishner
Journal:  Cancer Treat Rev       Date:  2008-03-04       Impact factor: 12.111

6.  Colorectal carcinoma in pregnancy.

Authors:  J C Nesbitt; K J Moise; J L Sawyers
Journal:  Arch Surg       Date:  1985-05

7.  Successful surrogate pregnancy after ovarian transposition, pelvic irradiation and hysterectomy.

Authors:  Michael Zinger; James H Liu; Nader Husseinzadeh; Michael A Thomas
Journal:  J Reprod Med       Date:  2004-07       Impact factor: 0.142

Review 8.  [Colorectal cancer discovered during pregnancy].

Authors:  M Chourak; M H Tahiri; A Majbar; M Allala; M Najih; H Iraki; M Yaka; A Ehrichou; S Alkandry
Journal:  Gastroenterol Clin Biol       Date:  2009-12
  8 in total
  1 in total

Review 1.  Does lower gastrointestinal endoscopy during pregnancy pose a risk for mother and child? - a systematic review.

Authors:  Alison De Lima; Boris Galjart; Pieter H A Wisse; Wichor M Bramer; C Janneke van der Woude
Journal:  BMC Gastroenterol       Date:  2015-02-12       Impact factor: 3.067

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.